Screening for mild cognitive impairment in patients with cardiovascular risk factors

Teodora Yaneva-Sirakova,1 Latchezar Traykov,2 Julia Petrova,2 Ivan Gruev,3 Dobrin Vassilev1 1Department of Internal Medicine, Cardiology Clinic, 2Department of Neurology, Neurology Clinic, Medical University Sofia, 3Cardiology Clinic, National Transport Hospital “Tsar Boris III”...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yaneva-Sirakova T, Traykov L, Petrova J, Gruev I, Vassilev D
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/c21f9c89624a48cfbfa4d89799c45158
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c21f9c89624a48cfbfa4d89799c45158
record_format dspace
spelling oai:doaj.org-article:c21f9c89624a48cfbfa4d89799c451582021-12-02T08:15:47ZScreening for mild cognitive impairment in patients with cardiovascular risk factors1178-2021https://doaj.org/article/c21f9c89624a48cfbfa4d89799c451582017-12-01T00:00:00Zhttps://www.dovepress.com/screening-for-mild-cognitive-impairment-in-patients-with-cardiovascula-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Teodora Yaneva-Sirakova,1 Latchezar Traykov,2 Julia Petrova,2 Ivan Gruev,3 Dobrin Vassilev1 1Department of Internal Medicine, Cardiology Clinic, 2Department of Neurology, Neurology Clinic, Medical University Sofia, 3Cardiology Clinic, National Transport Hospital “Tsar Boris III”, Sofia, Bulgaria Aim: Cardiovascular risk factors are also risk factors for cognitive impairment. They have cumulative effect in target organ damage. The precise correlation between cardiovascular risk factors and cognitive impairment, as well as assessing the extent to which they may affect cognitive functioning, is difficult to ascertain in everyday clinical practice. Quick, specific, and sensitive neuropsychological tests may be useful in screening for, and the prophylaxis of, target organ damage in hypertensive patients.Methods: We gathered full anamnesis, performed physical examination, laboratory screening and echocardiography. These variables were observed at office and home for all patients, For half of the patients, 24-hour ambulatory blood pressure monitoring and neuropsychological testing using Montreal Cognitive Assessment (MoCA), Mini Mental State Examination (MMSE), Geriatric Depression Scale, and the 4-instrumental activities of daily living scale were undertaken.Results: For a period of 2 years, 931 patients were included after applying the inclusion and exclusion criteria. The mean age was 65.90±10.00 years. Two hundred and sixty three patients (85 [32.32%] males and 178 [67.68%] females) were reevaluated after a mean follow-up period of 12 months (6–20 months). The mean results of MoCA and MMSE were significantly lower (p<0.05) in the group of patients with poorly controlled blood pressure and cardiovascular risk factors. There was mild to intermediate negative correlation between Systematic Coronary Risk Evaluation (SCORE) and the neuropsychological tests’ results.Conclusion: Cardiovascular risk factors play an important role for the development of cognitive impairment in the eastern European population because of their high frequency and interaction. The use of easily applicable neuropsychological tests in everyday clinical practice of specialties other than neurology may help in stratifying the risk for development and progression of mild cognitive impairment in this high-risk group. Keywords: arterial hypertension, cardiovascular risk factors, mild cognitive impairment, MoCA, pulse pressure, systolic pressureYaneva-Sirakova TTraykov LPetrova JGruev IVassilev DDove Medical Pressarticlearterial hypertensioncardio-vascular risk factorsmild cognitive impairmentNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 2925-2934 (2017)
institution DOAJ
collection DOAJ
language EN
topic arterial hypertension
cardio-vascular risk factors
mild cognitive impairment
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle arterial hypertension
cardio-vascular risk factors
mild cognitive impairment
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Yaneva-Sirakova T
Traykov L
Petrova J
Gruev I
Vassilev D
Screening for mild cognitive impairment in patients with cardiovascular risk factors
description Teodora Yaneva-Sirakova,1 Latchezar Traykov,2 Julia Petrova,2 Ivan Gruev,3 Dobrin Vassilev1 1Department of Internal Medicine, Cardiology Clinic, 2Department of Neurology, Neurology Clinic, Medical University Sofia, 3Cardiology Clinic, National Transport Hospital “Tsar Boris III”, Sofia, Bulgaria Aim: Cardiovascular risk factors are also risk factors for cognitive impairment. They have cumulative effect in target organ damage. The precise correlation between cardiovascular risk factors and cognitive impairment, as well as assessing the extent to which they may affect cognitive functioning, is difficult to ascertain in everyday clinical practice. Quick, specific, and sensitive neuropsychological tests may be useful in screening for, and the prophylaxis of, target organ damage in hypertensive patients.Methods: We gathered full anamnesis, performed physical examination, laboratory screening and echocardiography. These variables were observed at office and home for all patients, For half of the patients, 24-hour ambulatory blood pressure monitoring and neuropsychological testing using Montreal Cognitive Assessment (MoCA), Mini Mental State Examination (MMSE), Geriatric Depression Scale, and the 4-instrumental activities of daily living scale were undertaken.Results: For a period of 2 years, 931 patients were included after applying the inclusion and exclusion criteria. The mean age was 65.90±10.00 years. Two hundred and sixty three patients (85 [32.32%] males and 178 [67.68%] females) were reevaluated after a mean follow-up period of 12 months (6–20 months). The mean results of MoCA and MMSE were significantly lower (p<0.05) in the group of patients with poorly controlled blood pressure and cardiovascular risk factors. There was mild to intermediate negative correlation between Systematic Coronary Risk Evaluation (SCORE) and the neuropsychological tests’ results.Conclusion: Cardiovascular risk factors play an important role for the development of cognitive impairment in the eastern European population because of their high frequency and interaction. The use of easily applicable neuropsychological tests in everyday clinical practice of specialties other than neurology may help in stratifying the risk for development and progression of mild cognitive impairment in this high-risk group. Keywords: arterial hypertension, cardiovascular risk factors, mild cognitive impairment, MoCA, pulse pressure, systolic pressure
format article
author Yaneva-Sirakova T
Traykov L
Petrova J
Gruev I
Vassilev D
author_facet Yaneva-Sirakova T
Traykov L
Petrova J
Gruev I
Vassilev D
author_sort Yaneva-Sirakova T
title Screening for mild cognitive impairment in patients with cardiovascular risk factors
title_short Screening for mild cognitive impairment in patients with cardiovascular risk factors
title_full Screening for mild cognitive impairment in patients with cardiovascular risk factors
title_fullStr Screening for mild cognitive impairment in patients with cardiovascular risk factors
title_full_unstemmed Screening for mild cognitive impairment in patients with cardiovascular risk factors
title_sort screening for mild cognitive impairment in patients with cardiovascular risk factors
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/c21f9c89624a48cfbfa4d89799c45158
work_keys_str_mv AT yanevasirakovat screeningformildcognitiveimpairmentinpatientswithcardiovascularriskfactors
AT traykovl screeningformildcognitiveimpairmentinpatientswithcardiovascularriskfactors
AT petrovaj screeningformildcognitiveimpairmentinpatientswithcardiovascularriskfactors
AT gruevi screeningformildcognitiveimpairmentinpatientswithcardiovascularriskfactors
AT vassilevd screeningformildcognitiveimpairmentinpatientswithcardiovascularriskfactors
_version_ 1718398623739281408